VanEck Vectors Biotech ETF (BBH)
BBH is a passive ETF by VanEck tracking the investment results of the MVIS US Listed Biotech 25 Index. BBH launched on Dec 20, 2011 and has a 0.35% expense ratio.
ETF Info
ISIN | US92189F7261 |
---|---|
CUSIP | 92189F726 |
Issuer | VanEck |
Inception Date | Dec 20, 2011 |
Region | North America (U.S.) |
Category | Health & Biotech Equities |
Index Tracked | MVIS US Listed Biotech 25 Index |
Home Page | www.vaneck.com |
Asset Class | Equity |
Asset Class Size | Multi-Cap |
Asset Class Style | Growth |
Expense Ratio
The VanEck Vectors Biotech ETF has a high expense ratio of 0.35%, indicating higher-than-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: BBH vs. ARKG, BBH vs. FBT, BBH vs. IBB, BBH vs. XBI, BBH vs. HELX, BBH vs. VGT, BBH vs. IBBQ, BBH vs. SMH, BBH vs. SPY, BBH vs. SCHD
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in VanEck Vectors Biotech ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
VanEck Vectors Biotech ETF had a return of -4.83% year-to-date (YTD) and -1.51% in the last 12 months. Over the past 10 years, VanEck Vectors Biotech ETF had an annualized return of 6.71%, while the S&P 500 had an annualized return of 10.55%, indicating that VanEck Vectors Biotech ETF did not perform as well as the benchmark.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | -4.83% | 6.33% |
1 month | -4.78% | -2.81% |
6 months | 7.11% | 21.13% |
1 year | -1.51% | 24.56% |
5 years (annualized) | 5.37% | 11.55% |
10 years (annualized) | 6.71% | 10.55% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 0.11% | -1.67% | 2.21% | |||||||||
2023 | -4.82% | -7.29% | 5.07% | 9.45% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
VanEck Vectors Biotech ETF(BBH)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for VanEck Vectors Biotech ETF (BBH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
VanEck Vectors Biotech ETF granted a 0.45% dividend yield in the last twelve months. The annual payout for that period amounted to $0.71 per share.
Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dividend | $0.71 | $0.71 | $0.75 | $0.40 | $0.61 | $0.47 | $0.55 | $0.68 | $0.33 | $0.34 | $0.00 | $0.00 |
Dividend yield | 0.45% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% | 0.00% | 0.00% |
Monthly Dividends
The table displays the monthly dividend distributions for VanEck Vectors Biotech ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | $0.00 | $0.00 | $0.00 | |||||||||
2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.71 |
2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.75 |
2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.40 |
2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.61 |
2019 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.47 |
2018 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.55 |
2017 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.68 |
2016 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.33 |
2015 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.34 |
2014 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
2013 | $0.00 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the VanEck Vectors Biotech ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the VanEck Vectors Biotech ETF was 72.69%, occurring on Jul 10, 2002. Recovery took 1951 trading sessions.
The current VanEck Vectors Biotech ETF drawdown is 27.94%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-72.69% | Mar 6, 2000 | 591 | Jul 10, 2002 | 1951 | Mar 19, 2010 | 2542 |
-39.86% | Aug 10, 2021 | 213 | Jun 13, 2022 | — | — | — |
-33.76% | Jul 21, 2015 | 140 | Feb 8, 2016 | 975 | Dec 20, 2019 | 1115 |
-22% | Feb 25, 2014 | 34 | Apr 11, 2014 | 94 | Aug 26, 2014 | 128 |
-20.88% | Feb 24, 2020 | 16 | Mar 16, 2020 | 23 | Apr 17, 2020 | 39 |
Volatility
Volatility Chart
The current VanEck Vectors Biotech ETF volatility is 4.86%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.